With our outstanding nanobody discovery platforms and experienced scientists, we offer guaranteed nanobody drug screening services to worldwide customers.
As a rising star in macromolecule drugs, NDC is becoming the next blockbuster in antibody drug conjugation territory; with our proprietary site-specific conjugation technology, we provide one-stop NDC discovery solutions to our customers.
Benefitting from the distinct features of nanobody, it can be manufactured with yeast cells at large scale. Our GMP production center of excellence offer complete nanobody production services covering strain development and banking, process development, formulation development, etc.
Full human antibody can be generated using humanized mice, in which the variable regions of heavy or light chain are replaced with human germline VDJ region.
Traditional hybridoma technology is still the center of art in generating mouse monoclonal antibody.
Protein thermal stability is one of the key factors influencing its developability. NanotemperDSF is a new gold standard for biologics characterization
Empowering Global Biopharmaceutical Development
iCareAb is committed to the development of tumor immunotherapy technology, providing flow cytometry antibodies for multiple popular targets.
Several recombinant proteins, which are popular targets for tumor immunotherapy, are expressed using mammalian cell lines.
Provide high-quality CAR-T/TCR-T cell drug development services to meet the requirements of in vivo and in vitro pharmacodynamic evaluation experiments.
Leave your contact information, we will contact you as soon as possible and provide you with the required product list and quotation
Contact Us